APLS

Apellis Pharmaceuticals, Inc.

SCoRE: 43

LAST PRICE - AT THE CLOSE

APLS is DOWN -39% since the begininning of the year

APLS is DOWN -15% BELOW 20 day SMA

APLS is DOWN -38% BELOW 200 day SMA

View More APLS Price Action

PROFITABLE: NO
EPS: $-0.29

EARNINGS MOMENTUM: YES
0.16% INCREASE IN QTRLY EARNINGS

P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00

REVENUE IS: 781M

DEBT IS: 470K

CASH IS: 413M

	THE STOCK IS 79.5% AWAY FROM ALL-TIME HIGHS OF $94.75
	APLS IS DOWN -39% SINCE THE BEGINNING OF THE YEAR
	APLS IS DOWN -65% OVER THE PAST 12 MONTHS
	APLS IS DOWN -20% OVER THE PAST 1 MONTH
	27% OF ALL APLS INVESTORS ARE BETTING AGAINST APLS
	NUM INVESTORS SHORT APLS HAS GONE UP N/A% VERSUS LAST MONTH